Contact us on +44 (0)1270 270010 | info@boydconsultants.com

How Brexit affects UK procedures related to medicinal products

How Brexit affects UK procedures related to medicinal products
July 5, 2018 SueCarr

Practical guidance for procedures related to Brexit for medicinal products for human and veterinary use within the framework of the centralised procedure

In view of the considerable uncertainties, in particular concerning the content of a possible withdrawal agreement, MAHs of centrally authorised medicinal products for human and veterinary use are reminded of certain legal consequences that need to be considered in a timely manner. Subject to any transitional arrangement that may be contained in a possible withdrawal agreement, as of the withdrawal date, the EU rules in the field of medicinal products for human and veterinary use no longer apply to the United Kingdom.

For more information on this, click here.